药物诱导低温在急性缺血性卒中中的转化潜力
该研究通过小鼠、恒河猴模型及一项双盲1期临床试验(NCT06663631,32例急性缺血性卒中患者),评估氯丙嗪联合异丙嗪(C+P)诱导低温的可行性与安全性。动物实验显示C+P降低体温、抑制脑葡萄糖代谢、减小梗死体积并改善神经功能;临床试验中10、20、50、100毫克剂量均安全耐受,仅100毫克引起轻度短暂体温下降,血浆蛋白组学提示有氧呼吸和葡萄糖代谢标志物下调。
要点
- C+P在小鼠和恒河猴卒中模型中诱导低温并展现脑保护效应。
- 1期试验中C+P各剂量安全耐受,仅100毫克引起轻度短暂体温下降。
- 血浆蛋白组学显示C+P下调有氧呼吸和葡萄糖代谢相关标志物。
核心结论
- C+P药物诱导低温在急性缺血性卒中中具有转化潜力,需更大规模试验进一步评估安全性和有效性。
研究设计与样本
- 临床前研究:小鼠大脑中动脉线栓闭塞模型及恒河猴卒中模型。
- 临床研究:双盲1期临床试验(NCT06663631),共纳入32例急性缺血性卒中患者,随机接受安慰剂或C+P递增剂量10、20、50、100毫克。
主要发现
- 小鼠中C+P诱导低温并抑制脑葡萄糖代谢,减小梗死体积并改善神经功能缺损。
- 恒河猴卒中模型中C+P降低体温、抑制代谢并发挥脑保护作用。
- 1期试验中所有剂量C+P均安全且耐受良好,仅100毫克导致轻度短暂体温下降。
- 血浆蛋白组学显示C+P下调有氧呼吸和葡萄糖代谢相关标志物。
临床怎么用
- C+P诱导低温策略目前处于早期临床转化阶段,尚不能用于常规临床实践。
局限性
- 1期试验样本量较小(32例),仅评估安全性和耐受性。
- 仅100毫克剂量观察到轻度短暂体温下降,低温效果有限。
- 需更大规模试验进一步验证安全性和有效性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hypothermia and hypometabolism are important for hibernating animals to survive harsh environmental conditions. Induction of a hypothermic and hypometabolic state is considered an avenue to treat severe diseases, such as ischemic stroke. However, noninvasive and safe methods to achieve a long-lasting hypothermic and hypometabolic state remain limited. Here, we present data from preclinical and clinical studies to explore the feasibility and safety of drug-induced hypothermia by administration of chlorpromazine and promethazine (C+P). In mice, C+P treatment induced hypothermia and suppressed glucose metabolism in the brain. C+P treatment reduced infarct volumes and improved neurological deficit in a mouse middle cerebral artery occlusion model induced by suture insertion. Furthermore, C+P treatment reduced body temperature, suppressed metabolism, and exerted cerebroprotective effects in a rhesus monkey model of stroke. In a double-blind, phase 1 clinical trial (NCT06663631), a total of 32 patients diagnosed with acute ischemic stroke were enrolled, receiving either placebo or increasing doses of C+P treatment: 10, 20, 50, or 100 milligrams. All doses were safe and well tolerated. Only 100 milligrams of C+P resulted in a modest and transient reduction in body temperature. Plasma proteomic profiling revealed a down-regulation of markers associated with aerobic respiration and glucose metabolism. These findings highlight the translational potential of C+P treatment and warrant a larger trial to further investigate safety and efficacy of C+P.
引用
- Xu S, Wang Q, An H, et al. The translational potential of drug-induced hypothermia in acute ischemic stroke. Sci Transl Med. 2026. PMID: 42308333. doi:10.1126/scitranslmed.ady7847
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。